APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nivolumab Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nivolumab Injection Industry Growth and Trends Forecast to 2032

2 January 202690 pages

Choose your research edition.

Industry ResearchNivolumab Injection Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Nivolumab Injection Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Nivolumab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nivolumab Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Nivolumab Injection Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Nivolumab Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nivolumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nivolumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nivolumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nivolumab Injection include Sinopharm, AbbVie, Ono Pharmaceutical, Bristol-Myers Squibb and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nivolumab Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nivolumab Injection market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nivolumab Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nivolumab Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nivolumab Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nivolumab Injection Market by Company

Sinopharm

AbbVie

Ono Pharmaceutical

Bristol-Myers Squibb

Allergan

Nivolumab Injection Segment by Type

100IU

50IU

Other

Nivolumab Injection Segment by Application

Metastatic Squamous NSCLC

Metastatic Melanoma

Renal Cell Carcinoma

Classical Hodgkin Lymphoma

Unresectable Melanoma

Other

Nivolumab Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nivolumab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nivolumab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nivolumab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nivolumab Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nivolumab Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100IU Table 2. Major Company of 50IU Table 3. Major Company of Other Table 4. Global Nivolumab Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Nivolumab Injection Sales by Type (2021-2026) & (Units) Table 6. Global Nivolumab Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Nivolumab Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Nivolumab Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Nivolumab Injection Price by Type (2021-2026) & (US$/Unit) Table 10. Global Nivolumab Injection Sales by Type (2027-2032) & (Units) Table 11. Global Nivolumab Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Nivolumab Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Nivolumab Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Nivolumab Injection Price by Type (2027-2032) & (US$/Unit) Table 15. North America Nivolumab Injection Sales by Type (2021-2026) & (Units) Table 16. North America Nivolumab Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Nivolumab Injection Sales by Type (2021-2026) & (Units) Table 18. Europe Nivolumab Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Nivolumab Injection Sales by Type (2021-2026) & (Units) Table 20. Asia-Pacific Nivolumab Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Nivolumab Injection Sales by Type (2021-2026) & (Units) Table 22. Latin America Nivolumab Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Nivolumab Injection Sales by Type (2021-2026) & (Units) Table 24. Middle East and Africa Nivolumab Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Nivolumab Injection Industry Trends Table 26. Nivolumab Injection Industry Drivers Table 27. Nivolumab Injection Industry Opportunities and Challenges Table 28. Nivolumab Injection Industry Restraints Table 29. Global Nivolumab Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Nivolumab Injection Revenue Market Share by Company (2021-2026) Table 31. Global Nivolumab Injection Sales by Company (2021-2026) & (Units) Table 32. Global Nivolumab Injection Sales Share by Company (2021-2026) Table 33. Global Nivolumab Injection Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Nivolumab Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Nivolumab Injection Major Company Production Sites and Headquarters Table 36. Global Nivolumab Injection Company, Product Type & Application Table 37. Global Nivolumab Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Nivolumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Nivolumab Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Nivolumab Injection Sales by Region (2021-2026) & (Units) Table 42. Global Nivolumab Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Nivolumab Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Nivolumab Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Nivolumab Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Nivolumab Injection Sales by Region (2027-2032) & (Units) Table 47. Global Nivolumab Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Nivolumab Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Nivolumab Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Nivolumab Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Nivolumab Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Nivolumab Injection Sales by Application (2021-2026) & (Units) Table 53. Global Nivolumab Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Nivolumab Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Nivolumab Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Nivolumab Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Nivolumab Injection Sales by Application (2027-2032) & (Units) Table 58. Global Nivolumab Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Nivolumab Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Nivolumab Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Nivolumab Injection Price by Application (2027-2032) & (US$/Unit) Table 62. North America Nivolumab Injection Sales by Application (2021-2026) & (Units) Table 63. North America Nivolumab Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Nivolumab Injection Sales by Application (2021-2026) & (Units) Table 65. Europe Nivolumab Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Nivolumab Injection Sales by Application (2021-2026) & (Units) Table 67. Asia-Pacific Nivolumab Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Nivolumab Injection Sales by Application (2021-2026) & (Units) Table 69. Latin America Nivolumab Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Nivolumab Injection Sales by Application (2021-2026) & (Units) Table 71. Middle East and Africa Nivolumab Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Sinopharm Company Information Table 73. Sinopharm Business Overview Table 74. Sinopharm Nivolumab Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sinopharm Nivolumab Injection Product Portfolio Table 76. Sinopharm Recent Development Table 77. AbbVie Company Information Table 78. AbbVie Business Overview Table 79. AbbVie Nivolumab Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. AbbVie Nivolumab Injection Product Portfolio Table 81. AbbVie Recent Development Table 82. Ono Pharmaceutical Company Information Table 83. Ono Pharmaceutical Business Overview Table 84. Ono Pharmaceutical Nivolumab Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Ono Pharmaceutical Nivolumab Injection Product Portfolio Table 86. Ono Pharmaceutical Recent Development Table 87. Bristol-Myers Squibb Company Information Table 88. Bristol-Myers Squibb Business Overview Table 89. Bristol-Myers Squibb Nivolumab Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Bristol-Myers Squibb Nivolumab Injection Product Portfolio Table 91. Bristol-Myers Squibb Recent Development Table 92. Allergan Company Information Table 93. Allergan Business Overview Table 94. Allergan Nivolumab Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Allergan Nivolumab Injection Product Portfolio Table 96. Allergan Recent Development Table 97. North America Nivolumab Injection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 98. North America Nivolumab Injection Sales by Country (2021-2026) & (Units) Table 99. North America Nivolumab Injection Sales Market Share by Country (2021-2026) Table 100. North America Nivolumab Injection Sales Forecast by Country (2027-2032) & (Units) Table 101. North America Nivolumab Injection Sales Market Share Forecast by Country (2027-2032) Table 102. North America Nivolumab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. North America Nivolumab Injection Market Size by Country (2021-2026) & (US$ Million) Table 104. North America Nivolumab Injection Market Share by Country (2021-2026) Table 105. North America Nivolumab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. North America Nivolumab Injection Market Share Forecast by Country (2027-2032) Table 107. Europe Nivolumab Injection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 108. Europe Nivolumab Injection Sales by Country (2021-2026) & (Units) Table 109. Europe Nivolumab Injection Sales Market Share by Country (2021-2026) Table 110. Europe Nivolumab Injection Sales Forecast by Country (2027-2032) & (Units) Table 111. Europe Nivolumab Injection Sales Market Share Forecast by Country (2027-2032) Table 112. Europe Nivolumab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Europe Nivolumab Injection Market Size by Country (2021-2026) & (US$ Million) Table 114. Europe Nivolumab Injection Market Share by Country (2021-2026) Table 115. Europe Nivolumab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Europe Nivolumab Injection Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Nivolumab Injection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Nivolumab Injection Sales by Country (2021-2026) & (Units) Table 119. Asia-Pacific Nivolumab Injection Sales Market Share by Country (2021-2026) Table 120. Asia-Pacific Nivolumab Injection Sales Forecast by Country (2027-2032) & (Units) Table 121. Asia-Pacific Nivolumab Injection Sales Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Nivolumab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Nivolumab Injection Market Size by Country (2021-2026) & (US$ Million) Table 124. Asia-Pacific Nivolumab Injection Market Share by Country (2021-2026) Table 125. Asia-Pacific Nivolumab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Asia-Pacific Nivolumab Injection Market Share Forecast by Country (2027-2032) Table 127. Latin America Nivolumab Injection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 128. Latin America Nivolumab Injection Sales by Country (2021-2026) & (Units) Table 129. Latin America Nivolumab Injection Sales Market Share by Country (2021-2026) Table 130. Latin America Nivolumab Injection Sales Forecast by Country (2027-2032) & (Units) Table 131. Latin America Nivolumab Injection Sales Market Share Forecast by Country (2027-2032) Table 132. Latin America Nivolumab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Latin America Nivolumab Injection Market Size by Country (2021-2026) & (US$ Million) Table 134. Latin America Nivolumab Injection Market Share by Country (2021-2026) Table 135. Latin America Nivolumab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Latin America Nivolumab Injection Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Nivolumab Injection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Nivolumab Injection Sales by Country (2021-2026) & (Units) Table 139. Middle East and Africa Nivolumab Injection Sales Market Share by Country (2021-2026) Table 140. Middle East and Africa Nivolumab Injection Sales Forecast by Country (2027-2032) & (Units) Table 141. Middle East and Africa Nivolumab Injection Sales Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Nivolumab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Nivolumab Injection Market Size by Country (2021-2026) & (US$ Million) Table 144. Middle East and Africa Nivolumab Injection Market Share by Country (2021-2026) Table 145. Middle East and Africa Nivolumab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Middle East and Africa Nivolumab Injection Market Share Forecast by Country (2027-2032) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Nivolumab Injection Distributors List Table 150. Nivolumab Injection Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Nivolumab Injection Image Figure 2. Global Nivolumab Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nivolumab Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Nivolumab Injection Sales (2021-2032) & (Units) Figure 5. 100IU Image Figure 6. Global 100IU Sales YoY Growth (2021-2032) & (Units) Figure 7. 50IU Image Figure 8. Global 50IU Sales YoY Growth (2021-2032) & (Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (Units) Figure 11. Global Nivolumab Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Nivolumab Injection Market Share by Type 2025 VS 2032 Figure 13. North America Nivolumab Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Nivolumab Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Nivolumab Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Nivolumab Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Nivolumab Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Nivolumab Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Nivolumab Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Nivolumab Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Nivolumab Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Nivolumab Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Nivolumab Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Metastatic Squamous NSCLC Image Figure 26. Global Metastatic Squamous NSCLC Sales YoY Growth (2021-2032) & (Units) Figure 27. Metastatic Melanoma Image Figure 28. Global Metastatic Melanoma Sales YoY Growth (2021-2032) & (Units) Figure 29. Renal Cell Carcinoma Image Figure 30. Global Renal Cell Carcinoma Sales YoY Growth (2021-2032) & (Units) Figure 31. Classical Hodgkin Lymphoma Image Figure 32. Global Classical Hodgkin Lymphoma Sales YoY Growth (2021-2032) & (Units) Figure 33. Unresectable Melanoma Image Figure 34. Global Unresectable Melanoma Sales YoY Growth (2021-2032) & (Units) Figure 35. Other Image Figure 36. Global Other Sales YoY Growth (2021-2032) & (Units) Figure 37. Global Nivolumab Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Nivolumab Injection Market Share by Application 2025 VS 2032 Figure 39. North America Nivolumab Injection Sales Market Share in Volume by Application in 2025 Figure 40. North America Nivolumab Injection Sales Market Share in Value by Application in 2025 Figure 41. Europe Nivolumab Injection Sales Market Share in Volume by Application in 2025 Figure 42. Europe Nivolumab Injection Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Nivolumab Injection Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Nivolumab Injection Sales Market Share in Value by Application in 2025 Figure 45. Latin America Nivolumab Injection Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Nivolumab Injection Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Nivolumab Injection Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Nivolumab Injection Sales Market Share in Value by Application in 2025 Figure 49. North America Nivolumab Injection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 50. North America Nivolumab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Nivolumab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Nivolumab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Nivolumab Injection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 54. Europe Nivolumab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Nivolumab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Nivolumab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Nivolumab Injection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 58. Asia-Pacific Nivolumab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Nivolumab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Nivolumab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Nivolumab Injection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 62. Latin America Nivolumab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Nivolumab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Nivolumab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Nivolumab Injection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 66. Middle East and Africa Nivolumab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Nivolumab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Nivolumab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Nivolumab Injection Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Nivolumab Injection Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • 100IU
  • 50IU
  • Other
Applications
  • Metastatic Squamous NSCLC
  • Metastatic Melanoma
  • Renal Cell Carcinoma
  • Classical Hodgkin Lymphoma
  • Unresectable Melanoma
  • Other
Companies covered
  • Sinopharm
  • AbbVie
  • Ono Pharmaceutical
  • Bristol-Myers Squibb
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nivolumab Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nivolumab Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nivolumab Injection Market by Type
  6. 1.3.1 100IU
  7. 1.3.2 50IU
  8. 1.3.3 Other
  9. 1.4 Global Nivolumab Injection Market Size by Type
  10. 1.4.1 Global Nivolumab Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Nivolumab Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Nivolumab Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Nivolumab Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Nivolumab Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Nivolumab Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Nivolumab Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Nivolumab Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nivolumab Injection Industry Trends
  2. 2.2 Nivolumab Injection Industry Drivers
  3. 2.3 Nivolumab Injection Industry Opportunities and Challenges
  4. 2.4 Nivolumab Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nivolumab Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Nivolumab Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Nivolumab Injection Price (2021-2026)
  4. 3.4 Global Nivolumab Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nivolumab Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Nivolumab Injection Company, Product Type & Application
  7. 3.7 Global Nivolumab Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nivolumab Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nivolumab Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nivolumab Injection Tier 1, Tier 2, and Tier 3
4 Nivolumab Injection Regional Status and Outlook
  1. 4.1 Global Nivolumab Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nivolumab Injection Historic Market Size by Region
  3. 4.2.1 Global Nivolumab Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nivolumab Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nivolumab Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nivolumab Injection Forecasted Market Size by Region
  7. 4.3.1 Global Nivolumab Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nivolumab Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nivolumab Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nivolumab Injection by Application
  1. 5.1 Nivolumab Injection Market by Application
  2. 5.1.1 Metastatic Squamous NSCLC
  3. 5.1.2 Metastatic Melanoma
  4. 5.1.3 Renal Cell Carcinoma
  5. 5.1.4 Classical Hodgkin Lymphoma
  6. 5.1.5 Unresectable Melanoma
  7. 5.1.6 Other
  8. 5.2 Global Nivolumab Injection Market Size by Application
  9. 5.2.1 Global Nivolumab Injection Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Nivolumab Injection Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Nivolumab Injection Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Nivolumab Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Nivolumab Injection Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Nivolumab Injection Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Nivolumab Injection Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Nivolumab Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sinopharm
  2. 6.1.1 Sinopharm Company Information
  3. 6.1.2 Sinopharm Business Overview
  4. 6.1.3 Sinopharm Nivolumab Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sinopharm Nivolumab Injection Product Portfolio
  6. 6.1.5 Sinopharm Recent Developments
  7. 6.2 AbbVie
  8. 6.2.1 AbbVie Company Information
  9. 6.2.2 AbbVie Business Overview
  10. 6.2.3 AbbVie Nivolumab Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AbbVie Nivolumab Injection Product Portfolio
  12. 6.2.5 AbbVie Recent Developments
  13. 6.3 Ono Pharmaceutical
  14. 6.3.1 Ono Pharmaceutical Company Information
  15. 6.3.2 Ono Pharmaceutical Business Overview
  16. 6.3.3 Ono Pharmaceutical Nivolumab Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ono Pharmaceutical Nivolumab Injection Product Portfolio
  18. 6.3.5 Ono Pharmaceutical Recent Developments
  19. 6.4 Bristol-Myers Squibb
  20. 6.4.1 Bristol-Myers Squibb Company Information
  21. 6.4.2 Bristol-Myers Squibb Business Overview
  22. 6.4.3 Bristol-Myers Squibb Nivolumab Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bristol-Myers Squibb Nivolumab Injection Product Portfolio
  24. 6.4.5 Bristol-Myers Squibb Recent Developments
  25. 6.5 Allergan
  26. 6.5.1 Allergan Company Information
  27. 6.5.2 Allergan Business Overview
  28. 6.5.3 Allergan Nivolumab Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Allergan Nivolumab Injection Product Portfolio
  30. 6.5.5 Allergan Recent Developments
7 North America by Country
  1. 7.1 North America Nivolumab Injection Sales by Country
  2. 7.1.1 North America Nivolumab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nivolumab Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Nivolumab Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nivolumab Injection Market Size by Country
  6. 7.2.1 North America Nivolumab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nivolumab Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Nivolumab Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nivolumab Injection Sales by Country
  2. 8.1.1 Europe Nivolumab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nivolumab Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Nivolumab Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nivolumab Injection Market Size by Country
  6. 8.2.1 Europe Nivolumab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nivolumab Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nivolumab Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nivolumab Injection Sales by Country
  2. 9.1.1 Asia-Pacific Nivolumab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nivolumab Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nivolumab Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nivolumab Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Nivolumab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nivolumab Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nivolumab Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nivolumab Injection Sales by Country
  2. 10.1.1 South America Nivolumab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nivolumab Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Nivolumab Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nivolumab Injection Market Size by Country
  6. 10.2.1 South America Nivolumab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nivolumab Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Nivolumab Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nivolumab Injection Sales by Country
  2. 11.1.1 Middle East and Africa Nivolumab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nivolumab Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nivolumab Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nivolumab Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Nivolumab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nivolumab Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nivolumab Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nivolumab Injection Value Chain Analysis
  2. 12.1.1 Nivolumab Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nivolumab Injection Production Mode & Process
  7. 12.2 Nivolumab Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nivolumab Injection Distributors
  10. 12.2.3 Nivolumab Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst